{
  "questions": [
    {
      "type": "factoid",
      "id": "56d0451c3975bb303a00000e",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          "Hedgehog",
          0.9691604379436779
        ],
        [
          "Hh pathway",
          0.5211563556800417
        ],
        [
          "Hh",
          0.4032999718385615
        ],
        [
          "Hedgehog pathway",
          0.02221472316584141
        ],
        [
          "Hh activation status and tumor response to the Hh pathway",
          0.01112093054592357
        ],
        [
          "Hh activation status and tumor response to the Hh",
          0.008605998808432713
        ],
        [
          "Hedgehog signalling",
          0.005508606915305832
        ],
        [
          "Hh pathway inhibitor sonidegib",
          0.005204310636509806
        ],
        [
          "Hh pathway inhibitor sonidegib (LDE225) was analyzed.",
          0.003931380566786722
        ],
        [
          "Hedgehog signalling inhibitor,",
          0.00235869547116194
        ],
        [
          "Hh activation using a threshold set a priori. The association between Hh",
          0.0014653211147740595
        ],
        [
          "Hh pathway activation status. In an independent validation study, Hh",
          0.0007257615467191371
        ],
        [
          "sonidegib, a Hedgehog",
          0.0005765455321288717
        ],
        [
          "Hh pathway inhibitor sonidegib (LDE225)",
          0.0005358791888913343
        ],
        [
          "H",
          0.000484853531462756
        ],
        [
          "the Hh pathway",
          0.00032469503986560063
        ],
        [
          "the Hh",
          0.00025126720418298487
        ],
        [
          "Hedge",
          0.00023220159344626676
        ],
        [
          "hog",
          0.00013262165424276568
        ],
        [
          "pathway",
          0.00012172343089700513
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56e6ec49edfc094c1f000005",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          "RANKL",
          1.364745211672596
        ],
        [
          "monoclonal antibody",
          0.76924632766212
        ],
        [
          "receptor activator of nuclear factor \u03baB ligand",
          0.3122881545705463
        ],
        [
          "RANKL)",
          0.3009201352662605
        ],
        [
          "nuclear factor \u03baB ligand",
          0.22884004397457428
        ],
        [
          "receptor activator of nuclear factor \u03baB",
          0.11683807066563916
        ],
        [
          "RANKL, in this disease.",
          0.10091315461417392
        ],
        [
          "nuclear factor \u03baB",
          0.08561717387519195
        ],
        [
          "antibody",
          0.08163256662103067
        ],
        [
          "human monoclonal antibody",
          0.07242487700313463
        ],
        [
          "Denosumab is a human monoclonal antibody",
          0.06276633279337224
        ],
        [
          "blocks receptor activator of nuclear factor \u03baB ligand",
          0.058367948103405544
        ],
        [
          "specifically blocks receptor activator of nuclear factor \u03baB ligand",
          0.041869833493447056
        ],
        [
          "the receptor activator of nuclear factor-\u03baB ligand (RANKL",
          0.033443150439971356
        ],
        [
          "(RANKL",
          0.023339635618190847
        ],
        [
          ".",
          0.022408384090717652
        ],
        [
          "blocks receptor activator of nuclear factor \u03baB",
          0.02183751879571692
        ],
        [
          "the receptor activator of nuclear factor-\u03baB ligand (RANKL)",
          0.017154428766135547
        ],
        [
          "nuclear factor-\u03baB ligand (RANKL",
          0.015761426087430187
        ],
        [
          "specifically blocks receptor activator of nuclear factor \u03baB",
          0.015664989186648146
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56c1f009ef6e39474100003c",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          "Gaucher disease type 1",
          0.9801081220904582
        ],
        [
          "Gaucher disease",
          0.7498116078559455
        ],
        [
          "Gaucher's disease type 1",
          0.6322682715529281
        ],
        [
          "Gaucher disease type 1: the ENGAGE randomized clinical trial. IMPORTANCE: Gaucher disease type 1",
          0.3601353478000003
        ],
        [
          "Gaucher's disease",
          0.35561746457164783
        ],
        [
          "Gaucher disease type 1 (GD1)",
          0.24899570781110772
        ],
        [
          "multiple myeloma and non-Hodgkin lymphoma. Gaucher disease",
          0.1363097641533084
        ],
        [
          "Gaucher",
          0.11064647071330985
        ],
        [
          "B-cell malignancy",
          0.09176192808633055
        ],
        [
          "Gaucher disease - a sphingolipidosis associated with a high risk of multiple myeloma",
          0.058590113297310134
        ],
        [
          "Gaucher disease type 1: the ENGAGE randomized clinical trial. IMPORTANCE: Gaucher disease",
          0.04561453083396252
        ],
        [
          "Gaucher disease type 1 (GD1",
          0.038585244190006876
        ],
        [
          "Gaucher disease type 1 (GD1).",
          0.03562263841496269
        ],
        [
          "multiple myeloma",
          0.026535724323217852
        ],
        [
          "multiple myeloma and non-Hodgkin lymphoma. Gaucher",
          0.023500175086046543
        ],
        [
          "multiple myeloma and non-Hodgkin lymphoma.",
          0.021760521241945427
        ],
        [
          "multiple myeloma and non-Hodgkin lymphoma",
          0.018819008325632727
        ],
        [
          "Gaucher disease;",
          0.013557777524020698
        ],
        [
          "Gaucher disease type 1: the ENGAGE randomized clinical trial. IMPORTANCE: Gaucher",
          0.010186042598562376
        ],
        [
          "type 1",
          0.0036984109549337736
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56c1f020ef6e394741000047",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          "FCD",
          1.1425839085222234
        ],
        [
          "focal cortical dysplasia",
          0.8079251283608517
        ],
        [
          "MCD",
          0.7500950023362307
        ],
        [
          "Epilepsy",
          0.6515185526782532
        ],
        [
          "focal cortical dysplasia type I",
          0.45705971571344095
        ],
        [
          "Epilepsia",
          0.24982852717719334
        ],
        [
          "focal cortical dysplasia type 2",
          0.2113329842366894
        ],
        [
          "focal cortical dysplasia and refractory epilepsy",
          0.12058919602112514
        ],
        [
          "cortical dysplasias (FCD) are a well-recognized cause of medically intractable epilepsy",
          0.05522136009005312
        ],
        [
          "FCD with an associated hippocampal sclerosis (HS) (type 3a). In contrast to the former FCD",
          0.054794715025355684
        ],
        [
          "cortical dysplasia",
          0.05343416110063935
        ],
        [
          "cortical dysplasia type I",
          0.04155387991601426
        ],
        [
          "FCD classification and descriptions of gross pathologic findings associated with FCD",
          0.04087456912480735
        ],
        [
          "Palmini et al focal cortical dysplasia type I",
          0.040669658454113244
        ],
        [
          "Palmini et al focal cortical dysplasia",
          0.02919307040258115
        ],
        [
          "refractory epilepsy",
          0.01985401305477453
        ],
        [
          "type I",
          0.019743386394549936
        ],
        [
          "focal cortical dysplasia type I (Ib vs Ic) or Palmini et al focal cortical dysplasia",
          0.019364578220959865
        ],
        [
          "epilepsy.",
          0.01315071723763695
        ],
        [
          "focal cortical dysplasia of Palmini type 1",
          0.009615014089513643
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56a8ee75a17756b72f000007",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          "LXXLL motifs",
          0.5734153016299112
        ],
        [
          "LXXLL motifs of Dax1 and the activation- and ligand-binding domains of Esrrb.",
          0.16106018332912433
        ],
        [
          "LXXLL",
          0.0525349898527967
        ],
        [
          ".",
          0.04024527946604178
        ],
        [
          "LXXLL motifs of Dax1 and the activation- and ligand-binding domains",
          0.03741751175572464
        ],
        [
          "LXXLL motifs of Dax1",
          0.03199579044427187
        ],
        [
          "Interaction of Dax1 and Esrrb was mediated through LXXLL motifs",
          0.026622317556769314
        ],
        [
          "Dax1 is a direct downstream target",
          0.021263862526506826
        ],
        [
          "Dax1 and Esrrb was mediated through LXXLL motifs",
          0.011732088032260663
        ],
        [
          "a direct downstream target",
          0.00733901202148838
        ],
        [
          "Dax1 is a direct downstream target of Esrrb",
          0.005750503533570269
        ],
        [
          "estrogen-related receptor beta",
          0.004438314790495524
        ],
        [
          "Dax1 and the activation- and ligand-binding domains of Esrrb.",
          0.003845350726627915
        ],
        [
          "Dax1 functions as a negative regulator",
          0.0034367435981375706
        ],
        [
          "LXXLL motifs of Dax1 and the activation- and ligand-binding domains of Esrrb",
          0.0033823525214296615
        ],
        [
          "Oct3/4-independent manner",
          0.0033582990584693235
        ],
        [
          "direct downstream target",
          0.003308727145521819
        ],
        [
          "downstream target",
          0.0032558571066449186
        ],
        [
          "negative regulator",
          0.0031363962459244657
        ],
        [
          "estrogen-related receptor beta)",
          0.002461118658282578
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56d860ad51531f7e33000002",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          "Christianson syndrome",
          1.4889809312675564
        ],
        [
          "Christianson syndrome. OBJECTIVE: Recently, Christianson syndrome",
          0.2834433008110756
        ],
        [
          "Christianson",
          0.11077016451495517
        ],
        [
          "Christianson syndrome. OBJECTIVE: Recently, Christianson",
          0.030892538577521313
        ],
        [
          "Christianson syndrome (CS)",
          0.024974917346614247
        ],
        [
          "Christianson syndrome,",
          0.02188844283766675
        ],
        [
          "Christianson syndrome. OBJECTIVE: Recently, Christianson syndrome (CS)",
          0.012570204177138666
        ],
        [
          "Christianson syndrome.",
          0.011639684990283982
        ],
        [
          "Angelman syndrome",
          0.0059546789865647974
        ],
        [
          "Angelman",
          0.0025925574770442584
        ],
        [
          "Christianson syndrome (CS",
          0.0018507057995983459
        ],
        [
          "Christianson syndrome. OBJECTIVE: Recently, Christianson syndrome (CS",
          0.0009314845550798053
        ],
        [
          "NHE6) are associated with Christianson syndrome",
          0.0008515989408313886
        ],
        [
          "(NHE6) are associated with Christianson syndrome",
          0.0006338376152270931
        ],
        [
          "Christianson syndrome, a syndromic form of X-linked intellectual disability",
          0.000362982512829796
        ],
        [
          "NHE6 (SLC9A6) causes Christianson syndrome",
          0.0003334974568210034
        ],
        [
          "syndrome",
          0.00013653265651203416
        ],
        [
          "Christianson syndrome with electrical status epilepticus during slow-wave sleep (ESES).",
          0.00012988525071682699
        ],
        [
          "with Christianson syndrome",
          0.00011605809250768307
        ],
        [
          ". OBJECTIVE: Recently, Christianson syndrome",
          0.00011425032689612951
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56df03c751531f7e3300000a",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          ".",
          0.9417653539752475
        ],
        [
          "fine-tuning the RNA life cycle",
          0.4843243657305133
        ],
        [
          "plant development",
          0.22780615775085614
        ],
        [
          "stability",
          0.18237469001610043
        ],
        [
          "most abundant modified base in eukaryotic mRNA and has been linked to diverse effects on mRNA fate.",
          0.1768460728352143
        ],
        [
          "formation of late simian virus 40 mRNAs.",
          0.15865449666421313
        ],
        [
          "mutational signatures",
          0.13668502118021478
        ],
        [
          "reduces mRNA stability",
          0.13292969175570832
        ],
        [
          "facilitates resolution of na\u00efve pluripotency toward differentiation",
          0.12305524648302986
        ],
        [
          "abundance",
          0.11912489019238823
        ],
        [
          "fine-tuning the RNA life cycle.",
          0.11607914090565535
        ],
        [
          "most abundant modified base in eukaryotic mRNA and has been linked to diverse effects on mRNA fate",
          0.11372141862583982
        ],
        [
          "diverse effects on mRNA fate.",
          0.11257865096921753
        ],
        [
          "resolution of na\u00efve pluripotency toward differentiation",
          0.10911770653941273
        ],
        [
          "terminating murine na\u00efve pluripotency",
          0.10536583264945901
        ],
        [
          "life cycle",
          0.10371367450760019
        ],
        [
          "potential roles in fine-tuning the RNA life cycle",
          0.09319392129718455
        ],
        [
          "most abundant modified",
          0.09066913384348381
        ],
        [
          "important for formation of late simian virus 40 mRNAs.",
          0.09014973920078094
        ],
        [
          "potential regulatory functions of this RNA modification.",
          0.07676705082419923
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56e0447a51531f7e3300000b",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          "viroids",
          4.572643872566799
        ],
        [
          "Viroids: petite RNA pathogens with distinguished talents. Viroids",
          0.37012191969977587
        ],
        [
          "satRNAs) and viroids",
          0.25087292928224253
        ],
        [
          "viroids.",
          0.2366863239260272
        ],
        [
          "viroids and viroidlike satellite RNAs",
          0.20094773915852285
        ],
        [
          ".",
          0.1448376254218353
        ],
        [
          "satRNAs",
          0.14231387063223178
        ],
        [
          "viroids. Research during the last 15 years has conclusively shown that viroids",
          0.10443283009010498
        ],
        [
          "satRNAs)",
          0.09677005624486539
        ],
        [
          "viroids and viroidlike satellite RNAs.",
          0.0661653193332521
        ],
        [
          "the viroids",
          0.06521975452520239
        ],
        [
          "satellite RNAs (satRNAs) and viroids",
          0.053632932555706614
        ],
        [
          "viroids,",
          0.04950476461350428
        ],
        [
          "(satRNAs) and viroids",
          0.04026699759536959
        ],
        [
          "viroids RNA secondary structures. I. The effect of single mutations. Viroids",
          0.03784688414268568
        ],
        [
          "the viroids.",
          0.03455995558892465
        ],
        [
          "satellite RNAs (satRNAs",
          0.03042460678080147
        ],
        [
          ". Research during the last 15 years has conclusively shown that viroids",
          0.030241004802676042
        ],
        [
          "viroids and viroidlike satellite RNAs. Contrary to earlier beliefs, viruses",
          0.024356965869164724
        ],
        [
          "(satRNAs",
          0.022842449773003235
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56d138fe3975bb303a000015",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          "PaDOD1",
          0.34586327501780767
        ],
        [
          "Beta vulgaris MYB1",
          0.2349151369985972
        ],
        [
          "DOPA",
          0.21632708565188066
        ],
        [
          "Beta vulgaris MYB1 (BvMYB1",
          0.20626972104775237
        ],
        [
          "PaDOD1 and PaDOD2",
          0.20203717660349144
        ],
        [
          "BvMYB1",
          0.19736391438160183
        ],
        [
          "PaDOD2",
          0.11138263105607743
        ],
        [
          "Beta vulgaris MYB1 (BvMYB1)",
          0.0930095627601235
        ],
        [
          "BvMYB1)",
          0.08899382462930451
        ],
        [
          "BvMYB1), regulates the betalain pathway in beets. Silencing BvMYB1",
          0.04137324028683101
        ],
        [
          "PaDOD",
          0.03265882690618161
        ],
        [
          "PaDOD1 and PaDOD2,",
          0.031222267529514586
        ],
        [
          "Beta vulgaris MYB1 (BvMYB",
          0.02350833260822021
        ],
        [
          "BvMYB",
          0.022493347644896855
        ],
        [
          "(BvMYB1",
          0.02075038138515631
        ],
        [
          "PaDOD2,",
          0.017212764321088675
        ],
        [
          "DOD, but also the supplementation of DOPA",
          0.01193874044851605
        ],
        [
          "MYB1",
          0.011882775256670171
        ],
        [
          "PaDOD2, that may be involved in the betalain biosynthesis. The deduced amino acid sequence of PaDOD1",
          0.01059146874235093
        ],
        [
          "MYB1 (BvMYB1",
          0.01043379651384971
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56c048acef6e39474100001c",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          "Telomerase",
          3.993355053657529
        ],
        [
          ".",
          0.19517947022192908
        ],
        [
          "telomerase enzymatic activity.",
          0.15779389198292126
        ],
        [
          "telomerase.",
          0.09415792872053425
        ],
        [
          "telomerase activity",
          0.09163837870282496
        ],
        [
          "phase 2 telomerase",
          0.06568681040262049
        ],
        [
          "telomerase inhibitor, was used to elucidate the effect of telomerase",
          0.022810133920337622
        ],
        [
          "human telomerase",
          0.019942135172968323
        ],
        [
          "HER2",
          0.019820674271396155
        ],
        [
          "Imetelstat, a phase 2 telomerase",
          0.015130955026003605
        ],
        [
          "telomerase inhibitor imetelstat.",
          0.014275813194492655
        ],
        [
          "telomerase inhibitor,",
          0.01081246448178357
        ],
        [
          "human telomerase (hTERC)",
          0.009326552367569352
        ],
        [
          ". It binds with high affinity to the template region of the RNA component of human telomerase",
          0.009100320954881263
        ],
        [
          "human telomerase (hTERC",
          0.007421053485405613
        ],
        [
          "2 telomerase",
          0.0064232342351157184
        ],
        [
          "telomerase inhibitor imetelstat",
          0.006365658605215949
        ],
        [
          "hTERC)",
          0.004901057156313537
        ],
        [
          "hTERC",
          0.003899726915007025
        ],
        [
          "telomerase (hTERC)",
          0.003681113315878993
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56ae70050a360a5e4500000f",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          "represses hematopoietic genes in erythroid cells",
          0.5974778167730226
        ],
        [
          "represses hematopoietic genes in erythroid cells.",
          0.19530034608468444
        ],
        [
          "represses hematopoietic genes",
          0.06213973033342059
        ],
        [
          ".",
          0.059171729905020995
        ],
        [
          "RUNX1-MYEF2, represses hematopoietic genes in erythroid cells",
          0.024725190806043282
        ],
        [
          "suppressed by RUNX1 via the newly identified partner MYEF2.",
          0.018928326494146858
        ],
        [
          "a subset of the target genes is suppressed by RUNX1 via the newly identified partner MYEF2.",
          0.00945778475285939
        ],
        [
          "RUNX1-MYEF2, represses hematopoietic genes in erythroid cells.",
          0.008082037836167146
        ],
        [
          "suppressed",
          0.005947584579786009
        ],
        [
          "target genes is suppressed by RUNX1 via the newly identified partner MYEF2.",
          0.004890307346822101
        ],
        [
          "a subset of the target genes is suppressed",
          0.0029717880644353862
        ],
        [
          "RUNX1-MYEF2, represses hematopoietic genes",
          0.002571504156301711
        ],
        [
          "target genes is suppressed",
          0.00153661321170508
        ],
        [
          "represses hematopoietic genes in erythroid cells. RUNX1",
          0.0014733294289024522
        ],
        [
          "RUNX1 via the newly identified partner MYEF2.",
          0.0011599369499428493
        ],
        [
          "MYEF2 is bound in undifferentiated cells and is lost upon differentiation",
          0.00092958544472541
        ],
        [
          "MYEF2.",
          0.000856475875725056
        ],
        [
          "suppressed by RUNX1 via the newly identified partner MYEF2",
          0.0008180068672307126
        ],
        [
          "RUNX1 is known to be an essential transcription factor for generating hematopoietic stem cells (HSC)",
          0.0006842742681798837
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56c4d14ab04e159d0e000003",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          "PiggyBac",
          0.8934547445902403
        ],
        [
          ".",
          0.7557746482803467
        ],
        [
          "Sleeping Beauty",
          0.41476235907059383
        ],
        [
          "the Sleeping Beauty",
          0.29765945260973153
        ],
        [
          "Sleeping Beauty, PiggyBac",
          0.23273969350743845
        ],
        [
          "Sleeping Beauty (SB or SB11), Tol2, and piggyBac",
          0.2053172214401996
        ],
        [
          "Sleeping Beauty (SB) and piggyBac (PB), for the generation of murine iPS.",
          0.1212574171581471
        ],
        [
          "Sleeping Beauty (SB or SB11),",
          0.06069779394662863
        ],
        [
          "piggyBac (PB)",
          0.056431951422774324
        ],
        [
          "piggyBac (PB), for the generation of murine iPS.",
          0.05549090218838331
        ],
        [
          "piggyBac (PB",
          0.05031759830574328
        ],
        [
          "Sleeping Beauty (SB)",
          0.04984963787717142
        ],
        [
          "the Sleeping Beauty (SB",
          0.048589113891903596
        ],
        [
          "the Sleeping Beauty (SB)",
          0.048197790901357444
        ],
        [
          "Sleeping Beauty (SB",
          0.04814090833849545
        ],
        [
          "Tol2, and piggyBac",
          0.04788504432057545
        ],
        [
          "Sleeping Beauty (SB or SB11), Tol2, and piggyBac (PB)",
          0.045120156051795174
        ],
        [
          "Sleeping Beauty (SB or SB11), Tol2, and piggyBac (PB",
          0.0433964745082596
        ],
        [
          "Sleeping Beauty (SB or SB11), Tol2,",
          0.0394476311096685
        ],
        [
          "Sleeping Beauty (SB or SB11)",
          0.03739500881752225
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56d1f790f22319765a000001",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          "EGFR",
          5.503520188733778
        ],
        [
          "epidermal growth factor receptor",
          2.3829659080518963
        ],
        [
          "epidermal growth factor receptor (EGFR",
          0.6114637834539901
        ],
        [
          "epidermal growth factor receptor (EGFR)",
          0.5125612581891297
        ],
        [
          "MEK",
          0.31754295796931714
        ],
        [
          "EGFR kinase",
          0.3171505624980675
        ],
        [
          "AKT",
          0.3027909528686333
        ],
        [
          "epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) in EGFR",
          0.225623338489617
        ],
        [
          "epidermal growth factor receptor gene",
          0.15271282647473283
        ],
        [
          "EGFR gene. However, resistance to the EGFR",
          0.12811900003454899
        ],
        [
          "ex19del",
          0.12596690285129175
        ],
        [
          "EGFR)",
          0.11070594151967797
        ],
        [
          "epidermal growth factor",
          0.09691660103682818
        ],
        [
          "epidermal growth factor receptor (EGFR) gene",
          0.09542099158933652
        ],
        [
          "epidermal growth factor receptor gene (EGFR",
          0.0728066881283717
        ],
        [
          "EGFR Tyrosine Kinase Inhibitors Enter the Clinic. The T790M mutation in EGFR",
          0.07156895504818013
        ],
        [
          "non-small cell lung cancer harboring EGFR",
          0.0554285645492874
        ],
        [
          "EGFR)-tyrosine kinase inhibitor (TKI) in EGFR",
          0.054079425705663785
        ],
        [
          "epidermal growth factor receptor (EGFR) gene initially respond well to EGFR",
          0.051448240291709746
        ],
        [
          "EGFR gene",
          0.043165857169522995
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56cf20eb3975bb303a000001",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          "blocker",
          2.1220002736612464
        ],
        [
          "antagonist",
          0.8383532911755803
        ],
        [
          "blockade",
          0.5856000445801706
        ],
        [
          "sensitivity to blockade",
          0.22905242473857534
        ],
        [
          "dihydropyridine blocker",
          0.15324261377978562
        ],
        [
          "block",
          0.15067134336903196
        ],
        [
          "L-type channel blocker",
          0.11856140748101471
        ],
        [
          "blockade by isradipine of the L-type currents",
          0.09388124409885072
        ],
        [
          "antagonist.",
          0.06685119902230878
        ],
        [
          "blocker isradipine.",
          0.061162707059294184
        ],
        [
          "channel blocker",
          0.049877912609672614
        ],
        [
          "calcium channel antagonist",
          0.03761482976933231
        ],
        [
          "sensitivity to blockade by isradipine of the L-type currents",
          0.03672084180548913
        ],
        [
          "enhancement of the peak",
          0.03451900472154609
        ],
        [
          ".",
          0.03435400234105504
        ],
        [
          "caused a significant enhancement of the peak",
          0.02899512478162483
        ],
        [
          "blocker of L-type channels",
          0.025611980258846496
        ],
        [
          "blocker, isradipine (5 microM), had no significant effect",
          0.022948028884423554
        ],
        [
          "significant enhancement of the peak",
          0.022592807480340833
        ],
        [
          "minor contribution",
          0.018336192548804368
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56e2acfe51531f7e33000014",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          "G1",
          1.0917057822339886
        ],
        [
          "S phase",
          1.0862724242719868
        ],
        [
          "anaphase",
          1.0552654171722835
        ],
        [
          "mitotic",
          0.9879849775382502
        ],
        [
          "G1 phase",
          0.6714210552248737
        ],
        [
          "S-phase",
          0.6661436515589516
        ],
        [
          "mitosis",
          0.35834761370680634
        ],
        [
          "late G1",
          0.3373719520790782
        ],
        [
          "meiosis",
          0.25588887879858535
        ],
        [
          "metaphase",
          0.19039854957278274
        ],
        [
          "metaphase to anaphase",
          0.1585074986066874
        ],
        [
          "mitosis.",
          0.15339953712874277
        ],
        [
          "anaphase proteolysis of Rad21 phosphorylated in the S phase",
          0.1458069728382402
        ],
        [
          "meiosis and mitosis",
          0.1334693213178141
        ],
        [
          "anaphase. The universal role of cohesin during anaphase",
          0.12254958441250056
        ],
        [
          "late G1 phase",
          0.11222278589213938
        ],
        [
          ".",
          0.07131522543940148
        ],
        [
          "the late G1 phase",
          0.0480359439946313
        ],
        [
          "anaphase in yeast.",
          0.028790718555422132
        ],
        [
          "anaphase.",
          0.025387031856570215
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56e2cec751531f7e33000015",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          ".",
          1.2611168919058622
        ],
        [
          "four-helix bundle",
          1.0433250968830148
        ],
        [
          "BET",
          0.9023970065637399
        ],
        [
          "four-helix bundle topology",
          0.8122679274577564
        ],
        [
          "four-helix",
          0.614602843929007
        ],
        [
          "acetyl-lysine motifs",
          0.4743500290268886
        ],
        [
          "all-alpha-helical",
          0.4447728327651646
        ],
        [
          "left-handed four-helix bundle topology",
          0.3314953931598398
        ],
        [
          "left-handed four-helix bundle",
          0.2671981171630266
        ],
        [
          "alpha-helical",
          0.2509745261191785
        ],
        [
          "angstrom",
          0.1877616369370584
        ],
        [
          "bind acetyl-lysine motifs",
          0.1865025179896491
        ],
        [
          "all-alpha-helical fold",
          0.15954836166813835
        ],
        [
          "four-helix bundle.",
          0.15544665307174027
        ],
        [
          "angstrom crystal structure of the double bromodomain reveals two side-by-side, four-helix",
          0.13129590188295348
        ],
        [
          "four-helix bundles",
          0.12725982850929388
        ],
        [
          "left-handed up-and-down four-helix bundle",
          0.09370041795080672
        ],
        [
          "alpha-helical fold",
          0.09002927227773011
        ],
        [
          "acetyl-lysine motifs.",
          0.08067036215092212
        ],
        [
          "four-helix bundle topology, with two short additional helices in a long connecting loop.",
          0.06995625528023847
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "569e731cca240fa209000003",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          ".",
          0.7835612336014227
        ],
        [
          "to map regulatory and transcriptional features to the human genome",
          0.6926617369941891
        ],
        [
          "provides comprehensive expression profiles",
          0.11231734616050446
        ],
        [
          "to map regulatory and transcriptional features to the human genome.",
          0.10909922179904151
        ],
        [
          "map regulatory and transcriptional features to the human genome",
          0.0868004011413094
        ],
        [
          "to map regulatory and transcriptional features",
          0.03525290229481681
        ],
        [
          "biomedical research.",
          0.026354503667479025
        ],
        [
          "functional annotation of the mammalian genome 5",
          0.0242028631663983
        ],
        [
          "map regulatory and transcriptional features to the human genome.",
          0.013671689528363444
        ],
        [
          "functional annotation",
          0.006693881373980187
        ],
        [
          "map regulatory and transcriptional features",
          0.00441769177818921
        ],
        [
          "biomedical research",
          0.003847710437425758
        ],
        [
          "functional annotation of the mammalian genome",
          0.0031838217105168644
        ],
        [
          "The functional annotation of the mammalian genome 5",
          0.001983743281288601
        ],
        [
          "to map",
          0.0017988929237054252
        ],
        [
          "annotation of the mammalian genome 5 (FANTOM5) project provides comprehensive expression profiles",
          0.001466564577780112
        ],
        [
          "research.",
          0.001258489342082755
        ],
        [
          "annotation of the mammalian genome 5",
          0.0012418956170158644
        ],
        [
          "functional annotation of the mammalian genome 5 (FANTOM5",
          0.0009667518330810507
        ],
        [
          "investigate chromatin features around a comprehensive set of transcription start sites",
          0.0006968035812423431
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "569e79ecceceede94d000002",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          "expanding the transcriptome and subsequent analyses",
          0.5322778496304681
        ],
        [
          "facilitated the comprehensive characterization of the mouse transcriptome",
          0.22102361381724833
        ],
        [
          "to produce a comprehensive picture of the mammalian transcriptome",
          0.21285802577005342
        ],
        [
          "expanding the transcriptome",
          0.167667269525307
        ],
        [
          "produce a comprehensive picture of the mammalian transcriptome",
          0.15117775824740506
        ],
        [
          "expanding the transcriptome and subsequent analyses.",
          0.12414598802746041
        ],
        [
          "facilitated the comprehensive characterization",
          0.08594566858355769
        ],
        [
          "focusing on expanding the transcriptome and subsequent analyses",
          0.0556354716125192
        ],
        [
          "aims to produce a comprehensive picture of the mammalian transcriptome",
          0.05426198542260309
        ],
        [
          "facilitated the comprehensive characterization of the mouse transcriptome,",
          0.03949381255336954
        ],
        [
          ".",
          0.017817768731003533
        ],
        [
          "focusing on expanding the transcriptome",
          0.017525147102213486
        ],
        [
          "research project focusing on expanding the transcriptome and subsequent analyses",
          0.01412078931662417
        ],
        [
          "to produce a comprehensive picture of the mammalian transcriptome,",
          0.013944998035901308
        ],
        [
          "focusing on expanding the transcriptome and subsequent analyses.",
          0.012976156339222129
        ],
        [
          "comprehensive characterization of the mouse transcriptome",
          0.01117751933838653
        ],
        [
          "produce a comprehensive picture of the mammalian transcriptome,",
          0.009904129920426151
        ],
        [
          "FANTOM consortium aims to produce a comprehensive picture of the mammalian transcriptome",
          0.00942314673248033
        ],
        [
          "collaboration research project focusing on expanding the transcriptome and subsequent analyses",
          0.007956341945080053
        ],
        [
          "international collaboration research project focusing on expanding the transcriptome",
          0.007414299007166454
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56c1f01def6e394741000045",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          "castration-resistant prostate cancer",
          1.2343071218874668
        ],
        [
          "prostate cancer",
          0.7987127619934595
        ],
        [
          "castration-resistant prostate",
          0.5276698399094831
        ],
        [
          "prostate",
          0.5148135150745515
        ],
        [
          "metastatic castration-resistant prostate cancer",
          0.14300659227846801
        ],
        [
          "castration-resistant prostate cancer.",
          0.1382426469498167
        ],
        [
          "pancreatitis",
          0.10221614016187723
        ],
        [
          "androgen",
          0.09286425115388867
        ],
        [
          "(enzalutamide,",
          0.08012646254240906
        ],
        [
          "metastatic castration-resistant prostate",
          0.07244448750660375
        ],
        [
          "prostate cancer.",
          0.0544976951010886
        ],
        [
          ".",
          0.04570124414133943
        ],
        [
          "(enzalutamide, abiraterone,",
          0.038577951413248476
        ],
        [
          "androgen axis (enzalutamide,",
          0.03732623205014624
        ],
        [
          "metastatic castration-resistant prostate cancer.",
          0.028277548848398715
        ],
        [
          "androgen axis (enzalutamide, abiraterone,",
          0.017971211017933534
        ],
        [
          "androgen axis",
          0.011470760686634602
        ],
        [
          "prostate cancer that progressed after docetaxel therapy.",
          0.010302397078656647
        ],
        [
          "enzalutamide,",
          0.009579517788663084
        ],
        [
          "pancreatitis,",
          0.0050282576605498105
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56a24dfffe92d6fd19000002",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          "induces skipping of dystrophin exon 51",
          0.5080696159541402
        ],
        [
          "skip exon 51",
          0.43953787113176185
        ],
        [
          ".",
          0.41508532499960843
        ],
        [
          "antisense oligomer",
          0.3981480654960723
        ],
        [
          "induces skipping",
          0.27537521062224246
        ],
        [
          "morpholino AO to skip exon 51",
          0.2205465034934079
        ],
        [
          "restored dystrophin",
          0.15331637148612884
        ],
        [
          "enabled dystrophin production",
          0.1346979380146801
        ],
        [
          "Eteplirsen restored dystrophin",
          0.10574682410179649
        ],
        [
          "induces skipping of dystrophin",
          0.09169138120999559
        ],
        [
          "dystrophin production",
          0.08523832097929364
        ],
        [
          "monitoring the outcome of therapeutic interventions and disease progression.",
          0.0839869094634982
        ],
        [
          "monitoring the progression of muscle weakness",
          0.06993769895865877
        ],
        [
          "monitoring the outcome of therapeutic interventions and disease progression",
          0.06874649947864121
        ],
        [
          "skip exon 51, eteplirsen (AVI-4658).",
          0.06472666778323559
        ],
        [
          "monitoring the progression of muscle weakness and indirectly the remaining muscle mass",
          0.058991635430274574
        ],
        [
          "treated intramuscularly with a morpholino AO to skip exon 51",
          0.0506535619903676
        ],
        [
          "a morpholino AO to skip exon 51",
          0.04053871806880084
        ],
        [
          "skipping of dystrophin exon 51",
          0.036265998903688416
        ],
        [
          "monitoring the outcome of therapeutic interventions",
          0.0353834722153513
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56c58f1b5795f9a73e000001",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          "Rickettsia prowazekii",
          1.6172753922210767
        ],
        [
          "alpha-proteobacteria",
          0.9553741749375014
        ],
        [
          "\u03b1-proteobacteria",
          0.6478253143469631
        ],
        [
          ".",
          0.6370675076016943
        ],
        [
          "Rickettsiaceae",
          0.5764999939816883
        ],
        [
          "Reclinomonas",
          0.4839378795483397
        ],
        [
          "proteobacteria",
          0.441947912473773
        ],
        [
          "alpha-proteobacterium.",
          0.4101544622444245
        ],
        [
          "alpha-proteobacterium",
          0.3554407122185686
        ],
        [
          "Reclinomonas americana",
          0.3339006084915306
        ],
        [
          "purple non-sulphur",
          0.3325426401270513
        ],
        [
          "purple non-sulphur bacteria",
          0.27376257310758695
        ],
        [
          "Rickettsia",
          0.2687528586398011
        ],
        [
          "Rickettsiaceae.",
          0.22682024231125233
        ],
        [
          "Rickettsiales.",
          0.20728956461898798
        ],
        [
          "alpha-proteobacteria.",
          0.136486428810013
        ],
        [
          "purple non-sulphur bacteria.",
          0.12214158936701866
        ],
        [
          "Rickettsiales",
          0.11671431827048254
        ],
        [
          "non-sulphur",
          0.05103342678586536
        ],
        [
          "purple bacterium. Mitochondria originated by permanent enslavement of purple non-sulphur",
          0.04441258996945897
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56d85e7751531f7e33000001",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          "SLC49",
          0.7815699134669591
        ],
        [
          "SLC49 family",
          0.06619204757864962
        ],
        [
          "Feline leukemia virus subgroup C receptor (FLVCR1), a member of the SLC49",
          0.06052343078630321
        ],
        [
          "SLC48",
          0.03142599902710685
        ],
        [
          "the SLC49",
          0.02330547820285882
        ],
        [
          "SLC48 family",
          0.006133844327713426
        ],
        [
          "FLVCR1), a member of the SLC49",
          0.005698728052502779
        ],
        [
          "Feline leukemia virus subgroup C receptor (FLVCR1), a member of the SLC49 family",
          0.0051257983978159494
        ],
        [
          "leukemia virus subgroup C receptor (FLVCR1), a member of the SLC49",
          0.002906761811247088
        ],
        [
          "(FLVCR1), a member of the SLC49",
          0.002492553482916349
        ],
        [
          "the SLC48",
          0.00202343983190823
        ],
        [
          "SLC48 and SLC49",
          0.0019924348097391403
        ],
        [
          "the SLC49 family",
          0.001973767535656332
        ],
        [
          "48",
          0.001856248630422453
        ],
        [
          "SLC49A1",
          0.001408078797974687
        ],
        [
          "SLC48 family,",
          0.001317036133173954
        ],
        [
          "49",
          0.001287616057179593
        ],
        [
          "SLC49 family of four paralogous genes,",
          0.001212022050613321
        ],
        [
          "subgroup C receptor (FLVCR1), a member of the SLC49",
          0.0010721692394404898
        ],
        [
          "FLVCR1), a member of the SLC49 family",
          0.00048263177981837163
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56c5c7915795f9a73e000004",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          ".",
          1.53789842772361
        ],
        [
          "mid-S phase",
          0.6103049282719976
        ],
        [
          "tissue-specific loci",
          0.48030771477445294
        ],
        [
          "In human cells",
          0.4569328638775539
        ],
        [
          "chromatin",
          0.4412787504760828
        ],
        [
          "KSHV latency control region",
          0.27794637333559985
        ],
        [
          "regions of the genome",
          0.2699802462948905
        ],
        [
          "chromatin immunoprecipitation for the cohesin subunit Rad21",
          0.2539141899046078
        ],
        [
          "V(H) region",
          0.2501585823309028
        ],
        [
          "the KSHV latency control region",
          0.2236196949718815
        ],
        [
          "Dlk1-Dio3 and the Kcnq1/Kcnq1ot1 loci.",
          0.16150817463379694
        ],
        [
          "liver-specific targets that are distinct from those found in breast cancer cells.",
          0.157764139954177
        ],
        [
          "Rad21",
          0.15585022812303193
        ],
        [
          "human cells",
          0.13844873453873496
        ],
        [
          "V(H) region and 2 other sites within the Igh locus.",
          0.13815717889910356
        ],
        [
          "in mid-S phase",
          0.12591636867037573
        ],
        [
          "at the KSHV latency control region",
          0.1101571400771553
        ],
        [
          "at chromatin boundaries",
          0.10466323547681322
        ],
        [
          "Dlk1-Dio3 and the Kcnq1/Kcnq1ot1 loci",
          0.10165114035781093
        ],
        [
          "at tissue-specific loci",
          0.09711005680942854
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56c5feb75795f9a73e000006",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          "F508del",
          1.8193032040266015
        ],
        [
          "Cystic fibrosis",
          1.7068248611811596
        ],
        [
          "deltaF508",
          0.9663008675042662
        ],
        [
          "delta F508",
          0.9349366641526808
        ],
        [
          "generalized exocrinopathy cystic fibrosis",
          0.5100986905060593
        ],
        [
          "single amino acid deletion",
          0.16615245864907596
        ],
        [
          "cystic fibrosis transmembrane conductance regulator",
          0.09735560221898946
        ],
        [
          "F508",
          0.08511279306239722
        ],
        [
          "cystic fibrosis transmembrane conductance regulator (CFTR),",
          0.08233664290244669
        ],
        [
          "cystic fibrosis transmembrane conductance regulator (CFTR), corresponds to a cAMP",
          0.05298891875396264
        ],
        [
          "exocrinopathy cystic fibrosis",
          0.03775091358178121
        ],
        [
          "The generalized exocrinopathy cystic fibrosis",
          0.03380336931294939
        ],
        [
          "deltaF508,",
          0.029180568298681146
        ],
        [
          "cystic fibrosis transmembrane conductance regulator (CFTR",
          0.01919861858274942
        ],
        [
          "Cystic fibrosis (CF)",
          0.0168352061405083
        ],
        [
          "a single amino acid deletion",
          0.01657427975646997
        ],
        [
          "F508) accounts for 70% of the disease alleles,",
          0.015551278938508757
        ],
        [
          "cystic fibrosis transmembrane conductance regulator (CFTR)",
          0.014934990163598253
        ],
        [
          "5T",
          0.012811873739424037
        ],
        [
          "F508del frequency, but lower 5T",
          0.012473730425910714
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56b710f276d8bf8d13000003",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          ".",
          1.7642850024902348
        ],
        [
          "juvenile Batten disease",
          0.7966216385766802
        ],
        [
          "Batten disease (juvenile-onset neuronal ceroid lipofuscinosis",
          0.44298301234400966
        ],
        [
          "Batten disease",
          0.29857747522215966
        ],
        [
          "neurons die by apoptosis",
          0.29449094568215545
        ],
        [
          "juvenile-onset neuronal ceroid lipofuscinosis",
          0.27118044894123416
        ],
        [
          "inhibition of cell proliferation",
          0.2512482226328101
        ],
        [
          "Juvenile neuronal ceroid lipofuscinosis",
          0.24897831494427608
        ],
        [
          "ceroid lipofuscinosis",
          0.24702785044231898
        ],
        [
          "juvenile Batten disease.",
          0.17531416614971598
        ],
        [
          "neurodegenerative disorder juvenile Batten disease",
          0.16208272555055087
        ],
        [
          "neuronal loss in Batten disease",
          0.13175185114642318
        ],
        [
          "neurons die by apoptosis.",
          0.12183850869188978
        ],
        [
          "neuronal loss",
          0.11586157954878361
        ],
        [
          "anti-neuronal death",
          0.11270170503036413
        ],
        [
          "Batten disease [juvenile-onset neuronal ceroid lipofuscinosis",
          0.10977958803890417
        ],
        [
          "neuronal loss in Batten disease has been shown to be due to a combination of apoptosis and autophagy",
          0.09478643857129206
        ],
        [
          "Juvenile neuronal ceroid lipofuscinosis (Batten disease",
          0.09208980081314652
        ],
        [
          "anti-neuronal death function",
          0.07166809670392248
        ],
        [
          "anti-neuronal death function.",
          0.06972917395237466
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56cf236f3975bb303a000002",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          "T-type",
          1.0887536525679873
        ],
        [
          ".",
          0.7776314181525549
        ],
        [
          "T",
          0.28074783996699126
        ],
        [
          "CaV3.2",
          0.18601707459877975
        ],
        [
          "T-channel",
          0.15909430730633525
        ],
        [
          "Ca(v)3.2 T-type",
          0.147178380793414
        ],
        [
          "T-type channel",
          0.1434509406893111
        ],
        [
          "thalamic T-type calcium (T channel) isoform CaV3.2",
          0.14002493976519736
        ],
        [
          "Ca(v) 3.2 among T channels.",
          0.13676759055909882
        ],
        [
          "Ca(v)3.2 T-type calcium channels",
          0.10419935178648404
        ],
        [
          "thalamic T-type",
          0.09385457809256206
        ],
        [
          "Ca(v)3.2",
          0.0804900932506561
        ],
        [
          "T-type channel blocker ethosuximide.",
          0.07842677485784086
        ],
        [
          "Ca(v)3.2 T-type calcium channels.",
          0.0616416048463594
        ],
        [
          "T-type calcium channels",
          0.053590011077208406
        ],
        [
          "CaV3",
          0.0484921910928143
        ],
        [
          "thalamic T-type calcium (T channel) isoform CaV3",
          0.03650264983200798
        ],
        [
          "Ca(v) 3.2",
          0.03513428656833965
        ],
        [
          "T-type calcium channels, we examined if more selective T-type",
          0.029238865104695526
        ],
        [
          "T-type calcium (T channel) isoform CaV3.2",
          0.028931260489119794
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56b7210b76d8bf8d13000004",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          ".",
          2.030159057610562
        ],
        [
          "inhibited adipocyte differentiation",
          0.8317707675993489
        ],
        [
          "increase TRAIL mRNA and protein expression",
          0.7246542851143016
        ],
        [
          "abolished 1-induced [Ca(2+)]i increases",
          0.7233447264094748
        ],
        [
          "largely reduced",
          0.6597700047036833
        ],
        [
          "potentiated the Cl(-) current",
          0.5321170745642799
        ],
        [
          "significantly more activity in the mouse JNCL cells",
          0.301586138272542
        ],
        [
          "UPR activation and apoptosis are reduced",
          0.2927871950493886
        ],
        [
          "drastic resistance against apoptosis",
          0.288936900625977
        ],
        [
          "Thapsigargin-induced ER stress",
          0.2568822735520258
        ],
        [
          "ER stress",
          0.23795594142914175
        ],
        [
          "abolished 1-induced [Ca(2+)]i increases.",
          0.23495191249144504
        ],
        [
          "reproducibly displayed significantly more activity in the mouse JNCL cells",
          0.22471214027141032
        ],
        [
          "drastic resistance",
          0.1871283109996758
        ],
        [
          "increased ERAD",
          0.16624846843443958
        ],
        [
          "UPR activation and apoptosis are reduced after mechanical unloading",
          0.16018035105238718
        ],
        [
          "thapsigargin and tunicamycin increased ERAD",
          0.15623940743606463
        ],
        [
          "UPR activation and apoptosis are reduced after mechanical unloading,",
          0.14811634068748256
        ],
        [
          "increase TRAIL",
          0.1274932854252604
        ],
        [
          "largely reduced these effects",
          0.12745750324103922
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56a8d660a17756b72f000006",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          ".",
          0.7711667233488805
        ],
        [
          "reduces contamination",
          0.01518852502661971
        ],
        [
          ". We describe here a simple procedure for greatly reducing contamination",
          0.010427122855410118
        ],
        [
          "reduces contamination by endogenous biotinylated carboxylases",
          0.007194804626358142
        ],
        [
          "NP-40 reduces contamination",
          0.005841439137010642
        ],
        [
          "NP-40 reduces contamination by endogenous biotinylated carboxylases",
          0.0027670898427526406
        ],
        [
          "contamination",
          0.0022548279647956744
        ],
        [
          "reduces contamination by endogenous biotinylated carboxylases during purification",
          0.0013020574372480966
        ],
        [
          "contamination by endogenous biotinylated carboxylases",
          0.0010681120546149677
        ],
        [
          "biotin tagged nuclear proteins.",
          0.0010347734431283874
        ],
        [
          "biotinylated carboxylases during purification of biotin tagged nuclear proteins.",
          0.0010193483669976608
        ],
        [
          "purification of biotin tagged nuclear proteins.",
          0.0007243685489198737
        ],
        [
          "non-specific background",
          0.0007116242583804676
        ],
        [
          ". We describe here a simple procedure for greatly reducing contamination of nuclear extracts",
          0.0006001881108218793
        ],
        [
          "NP-40 reduces contamination by endogenous biotinylated carboxylases during purification",
          0.0005007654962708081
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56d04a533975bb303a000010",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          "a receptor tyrosine kinase inhibitor",
          0.6644379476241689
        ],
        [
          "receptor tyrosine kinase inhibitor",
          0.193523841805689
        ],
        [
          "tyrosine kinase inhibitor",
          0.07493003826131107
        ],
        [
          "dovitinib (TKI258), a receptor tyrosine kinase inhibitor",
          0.026435334580353482
        ],
        [
          "(TKI258), a receptor tyrosine kinase inhibitor",
          0.0065256848342947
        ],
        [
          "a receptor tyrosine kinase inhibitor with potent activity against fibroblast growth factor receptor",
          0.005645805470426853
        ],
        [
          "TKI258), a receptor tyrosine kinase inhibitor",
          0.005324892999267312
        ],
        [
          "a receptor tyrosine kinase",
          0.004637197787586802
        ],
        [
          "kinase inhibitor",
          0.004249181569045992
        ],
        [
          "inhibitor",
          0.0021200954246142897
        ],
        [
          "receptor tyrosine kinase inhibitor with potent activity against fibroblast growth factor receptor",
          0.0016443942863760012
        ],
        [
          "receptor tyrosine kinase",
          0.001350627751282874
        ],
        [
          "tyrosine kinase inhibitor with potent activity against fibroblast growth factor receptor",
          0.0006366891316603293
        ],
        [
          "tyrosine kinase inhibitor with potent activity against fibroblast growth factor receptor (FGFR)",
          0.0005883289145889519
        ],
        [
          "tyrosine kinase",
          0.0005229463622473375
        ],
        [
          "fibroblast growth factor receptor (FGFR) and vascular endothelial growth factor receptor (VEGFR)",
          0.00025295568239274395
        ],
        [
          "dovitinib",
          0.00021294646687904396
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56e47e0051531f7e3300001c",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          "hypothalamic",
          2.234954871916289
        ],
        [
          "hypothalamus",
          1.0301432833544322
        ],
        [
          "paraventricular nucleus",
          0.6794331332298089
        ],
        [
          "hypothalamic paraventricular nucleus",
          0.5960733931124993
        ],
        [
          "the lateral hypothalamus",
          0.49813894192316654
        ],
        [
          "embryonic hypothalamic neurons",
          0.4441530461647828
        ],
        [
          "lateral hypothalamus",
          0.4225515875077602
        ],
        [
          "neuropeptide Y",
          0.3658212109871143
        ],
        [
          "hypothalamic paraventricular nucleus (PVN)",
          0.3488992624895486
        ],
        [
          "melanin-concentrating hormone and prepro-orexin.",
          0.33608406917098116
        ],
        [
          "perifornical lateral hypothalamus",
          0.28371639330619414
        ],
        [
          "Rubisco",
          0.27237523792370516
        ],
        [
          "embryonic hypothalamic",
          0.20814959806265543
        ],
        [
          "Alpha-lipoic acid",
          0.20299307308082604
        ],
        [
          "green leaf protein Rubisco",
          0.18935102841960433
        ],
        [
          "hypothalamic mRNA levels of the orexigenic peptides melanin-concentrating hormone and prepro-orexin.",
          0.18801579817135128
        ],
        [
          "rubiscolin-6, a \u03b4 opioid agonist hexapeptide derived from a major green leaf protein Rubisco",
          0.17540848056657105
        ],
        [
          "feed",
          0.15282624699686315
        ],
        [
          "prepro-orexin.",
          0.15231385978901302
        ],
        [
          "neuropeptide Y (NPY) and agouti-related protein (AgRP) decreased in the hypothalamus",
          0.12740025168102007
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "56d06e043975bb303a000011",
      "ideal_answer": "Dummy",
      "exact_answer": [
        [
          "Women with hormone receptor-positive, human epidermal growth factor receptor 2- negative",
          0.3208401582215358
        ],
        [
          "hormone receptor-positive, human epidermal growth factor receptor 2- negative breast cancer",
          0.0416754574122675
        ],
        [
          "hormone receptor-positive, human epidermal growth factor receptor 2- negative",
          0.0251748044768465
        ],
        [
          "Women",
          0.02474413484519243
        ],
        [
          "human epidermal growth factor receptor 2- negative breast cancer",
          0.019735269800718283
        ],
        [
          "human epidermal growth factor receptor 2- negative",
          0.011921442243958427
        ],
        [
          "Women with hormone receptor-positive",
          0.003285966390955859
        ],
        [
          "breast cancer",
          0.002036534996051335
        ],
        [
          "negative breast cancer",
          0.0018836463966101853
        ],
        [
          "Women with hormone receptor-positive,",
          0.001595888057560972
        ],
        [
          "negative",
          0.0011378502524658385
        ],
        [
          "Women with hormone receptor-positive, human epidermal growth factor receptor 2- negative breast",
          0.00096276999626717
        ],
        [
          "HR+, HER2- Breast Cancer. Women",
          0.0006703157097263733
        ],
        [
          "epidermal growth factor receptor 2- negative breast cancer",
          0.0005533842371779518
        ]
      ]
    }
  ]
}